Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Brain : a Journal of Neurology|March 13, 2016
Is Huntington's disease a tauopathy?Maud Gratuze, Giulia Cisbani, Francesca Cicchetti, et al.Trends in Pharmacological Sciences|September 5, 2009
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?Francesca Cicchetti, Janelle Drouin-Ouellet, Robert E GrossNeurobiology of Disease|August 10, 2019
Antibody-based therapies for Huntington's disease: current status and future directionsHélèna L Denis, Linda S David, Francesca CicchettiJournal of Neurology|March 6, 2025
Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severityMelanie Alpaugh, Juan Lantero-Rodriguez, Andrea L Benedet, et al.Journal of Neurology|April 12, 2024
Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseasesThyago R Cardim-Pires, Aurélie de Rus Jacquet, Francesca CicchettiMolecular Psychiatry|June 10, 2020
Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathologyMarie Rieux, Melanie Alpaugh, Giacomo Sciacca, et al.Neuroscience Letters|November 5, 2017
The effects of cysteamine in a mouse model of levodopa-induced dyskinesiasLinda S David, Martine Saint-Pierre, Jérôme Lamontagne-Proulx, et al.Journal of Neurochemistry|June 24, 2010
Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseasesMélanie Bousquet, Claire Gibrat, Mélissa Ouellet, et al.Frontiers in Neurology|December 17, 2020
Targeting Tau to Treat Clinical Features of Huntington's DiseaseMaria Masnata, Shireen Salem, Aurelie de Rus Jacquet, et al.Brain, Behavior, and Immunity|January 4, 2014
The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspringDany Arsenault, Isabelle St-Amour, Giulia Cisbani, et al.Pageof 10